ticlopidine has been researched along with Bernard-Soulier Syndrome in 1 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Bernard-Soulier Syndrome: A familial coagulation disorder characterized by a prolonged bleeding time, unusually large platelets, and impaired prothrombin consumption.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Z | 1 |
| Shi, J | 1 |
| Han, Y | 1 |
| Wang, Y | 1 |
| Bai, X | 1 |
| Lu, D | 1 |
| Ruan, C | 1 |
1 other study available for ticlopidine and Bernard-Soulier Syndrome
| Article | Year |
|---|---|
[Report of a patient with spontaneous aggregation of his giant and morphologically abnormal platelets].
Topics: Aspirin; Bernard-Soulier Syndrome; Blood Platelet Disorders; Cell Size; Child; Cytoplasmic Granules; | 2002 |